Reverse vaccinology: developing vaccines in the era of genomics
about
Vaccines: from empirical development to rational designCystoisospora suis - A Model of Mammalian CystoisosporosisA maternal vaccine against group B Streptococcus: past, present, and futureBeyond empiricism: informing vaccine development through innate immunity researchApproaches to vaccines against Orientia tsutsugamushiSystems biology in vaccine designRevealing the role of CD4(+) T cells in viral immunityVaccines against invasive Salmonella disease: current status and future directionsDiscovery of a protective Rickettsia prowazekii antigen recognized by CD8+ T cells, RP884, using an in vivo screening platformCattle Immunized with a Recombinant Subunit Vaccine Formulation Exhibits a Trend towards Protection against Histophilus somni Bacterial ChallengeStructure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial VirusIn vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopesRapid profiling of the antigen regions recognized by serum antibodies using massively parallel sequencing of antigen-specific librariesIn-silico screening, identification and validation of a novel vaccine candidate in the fight against Plasmodium falciparumTprC/D (Tp0117/131), a trimeric, pore-forming rare outer membrane protein of Treponema pallidum, has a bipartite domain structureSalmonella typhi Genomics: Envisaging the Future of Typhoid Eradication.Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06.A novel method for synthetic vaccine construction based on protein assemblyVaccines, new opportunities for a new society.Influenza research database: an integrated bioinformatics resource for influenza research and surveillance.Influenza vaccination in the face of immune exhaustion: is herd immunity effective for protecting the elderly?Whole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response.Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approachVaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.B-cell-lineage immunogen design in vaccine development with HIV-1 as a case studyTh17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumoniaMolecular characterization of an α-N-acetylgalactosaminidase from Clonorchis sinensis.Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity.Immunity to intracellular Salmonella depends on surface-associated antigens.Maternal vaccination: moving the science forward.Microbial genomics and infectious diseases.Immunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approachEnhancing in silico protein-based vaccine discovery for eukaryotic pathogens using predicted peptide-MHC binding and peptide conservation scores.Computational and experimental validation of B and T-cell epitopes of the in vivo immune response to a novel malarial antigenIdentification of conserved and HLA promiscuous DENV3 T-cell epitopes.Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine.In vivo and in vitro characterization of the immune stimulating activity of the Neisserial porin PorBVaccines and global health.The human condition: an immunological perspective.
P2860
Q21089599-E809267B-8A95-4B25-AF01-39CC9C0EAF9BQ26776047-2584FEC9-14CC-485F-8E13-3E84D2B1460DQ26822039-92D4F0AD-C628-4CCE-8CEF-50114A7A531AQ26824573-C1D5B0D9-4A0C-4C41-9E8D-6C5935B3C48FQ26849239-61DBBDFE-5180-40F5-9FCE-0933707AF87EQ26851326-FCD36169-1A56-4761-B512-99554EBB27BCQ26995409-C6B9BB55-FF2B-44E1-B718-6958E069AC51Q27007088-B1A86E44-58F1-4625-9677-EC1A542888A8Q27304785-4B055E5E-48D9-48BE-B36E-8F291181F2D0Q27334719-A747DE90-1146-4E97-B4C4-163494DA845CQ27680499-C4E3669B-12E5-45E7-BEB1-D4633B79A4E7Q28541967-22784D32-1564-4D4F-82F9-D87E0E04FFE0Q29048193-F9570B94-30D6-4F79-A2C6-B0EDA7BEC6AFQ30041123-53A3ADC8-7F51-43BF-B7FE-6E518112704CQ30155363-EBFFA6D6-D6C2-4D04-9C80-3F15080285BCQ30234360-C722CCF5-B91E-466F-BEC5-58EA1968E9E1Q30277773-B23182B3-25DE-4A16-9D10-76CEADF3C416Q30369012-AABF4AAD-6201-4BD3-8385-9BF0892AC3CBQ30390904-4C0CC80D-1CE8-4440-88C3-F41E2A9D47D7Q30411991-034EACEA-7848-4F21-9A4F-5E49FD55A444Q30422463-E5978FC5-5A51-419C-A5F8-954751ABDB5EQ33916280-1448D36F-82D0-405D-BDDE-36A23537716DQ34093166-0F8DFA31-1257-4C05-8579-26ED4A838E30Q34126261-4F5AB1D6-D20A-4A5F-8485-734EBCD9CD0DQ34225659-ED7D1F40-98CE-449B-9101-D0CEBC5A8C82Q34273373-C7A73EB4-FBF2-4F01-8115-119EEA1EDF6CQ34313640-0FAFF84F-5682-4AB4-8025-19F0C610050DQ34394949-CD58E7B4-2CC6-4737-9088-651F02120EA6Q34431155-42F076C6-71FF-4883-9971-C13A755EF424Q34456080-9C7295D8-FB99-45D6-BCE3-4D917CA34C28Q34630952-F3444EAB-CEDB-4F62-8349-F764D6F73876Q34631250-42E9069B-5A5B-4C63-A287-3DA2387CA9E5Q34637943-C38C5744-CD8E-4A31-8DAA-A6328D2B118AQ34783245-68ED22AC-CB59-40BC-8C87-445290511FC5Q34971618-5651833E-26E2-4323-AD3B-E2E24D32AA47Q35018972-535C0476-D472-4F0B-8A2D-DBB8D6456A3AQ35052264-0EFE84CD-C1E2-4A13-A493-550A6EE7BAD2Q35070034-D0D70F06-3C73-43E9-B7BF-22A6F75DC06FQ35137116-6F38C88E-75A9-452A-8523-F08CA2DCA3A6Q35188878-9D335B4F-FE87-49EF-9391-98A296C6AAF9
P2860
Reverse vaccinology: developing vaccines in the era of genomics
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Reverse vaccinology: developing vaccines in the era of genomics
@ast
Reverse vaccinology: developing vaccines in the era of genomics
@en
type
label
Reverse vaccinology: developing vaccines in the era of genomics
@ast
Reverse vaccinology: developing vaccines in the era of genomics
@en
prefLabel
Reverse vaccinology: developing vaccines in the era of genomics
@ast
Reverse vaccinology: developing vaccines in the era of genomics
@en
P2860
P1433
P1476
Reverse vaccinology: developing vaccines in the era of genomics
@en
P2860
P304
P356
10.1016/J.IMMUNI.2010.09.017
P407
P577
2010-10-01T00:00:00Z